N-Nitroso-N-methylurea
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Skeletal formula of N-nitroso-N-methylurea | |
Template:Chembox image sbs cell | |
Names | |
---|---|
IUPAC name
1-Methyl-1-nitrosourea[1]
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
KEGG | |
MeSH | Methylnitrosourea |
PubChem CID
|
|
| |
| |
Properties | |
C2H5N3O2 | |
Molar mass | 103.08 g·mol−1 |
Related compounds | |
Related compounds
|
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Overview
N-Nitroso-N-methylurea (NMU) is a highly reliable carcinogen, mutagen, and teratogen. NMU is an alkylating agent, and exhibits its toxicity by transferring its methyl group to nucleobases in nucleic acids, which can lead to AT:GC transition mutations.
NMU is the traditional precursor in the synthesis of diazomethane. However, since it is unstable at temperatures beyond 20 °C and shock-sensitive to a degree, for this purpose it has become obsolete and replaced by other (N-methyl)nitrosamides. Most chemical supply houses have stopped carrying it.
Acute exposure to NMU in humans can result in skin and eye irritation, headache, nausea, and vomiting.[2] NMU is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity in experimental animals (IARC 1972, 1978, 1987).[3] Various cancers induced in animal models include: squamous cell carcinomas of the forestomach, sarcomas and gliomas of the brain, adenocarcinomas of the pancreas, leukemia, and lymphomas.[3] However, the actual potential for human exposure is quite limited, as the chemical is not produced or used in large quantities [3]
NMU is teratogenic and embryotoxic, resulting in craniofacial (cleft palate) and skeletal defects, increased fetal resorption, and fetal growth retardation.[4][5][6] Exposure to NMU during pre-implantation, post-implantation, organogenesis, or by paternal exposure can result in these effects.
References
- ↑ "Methylnitrosourea - Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 26 March 2005. Identification. Retrieved 1 May 2012.
- ↑ Hazardous Substance Fact Sheet for NMU New Jersey Department of Health and Senior Services
- ↑ 3.0 3.1 3.2 NMU Substance Profile NTP, Report on Carcinogens, Eleventh Edition
- ↑ Wada, A., et al. (1994). Induction of Congenital Malformations in Mice by Paternal Methylnitrosourea Treatment. Congenital Anomalies 34:65-70.
- ↑ Nagao, T., et al. (1991). Induction of Fetal Malformations After Treatment of Mouse Embryos with Methylnitrosourea at the Preimplantation Stages. Teratogenesis, Carcinogenesis, and Mutagenesis 11:1-10.
- ↑ Faustman, E., et al. (1989). In Vitro Developmental Toxicity of Five Direct-Acting Alkylating Agents in Rodent Embryos: Structure-Activity Patterns. Teratology 40:199-210.
- Pages with script errors
- Pages with broken file links
- Chemical articles with multiple compound IDs
- Multiple chemicals in an infobox that need indexing
- Articles without InChI source
- Articles without UNII source
- Articles with changed EBI identifier
- Articles with changed ChemSpider identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Carcinogens
- Nitrosamines
- Ureas
- Nitrosoureas
- IARC Group 2A carcinogens
- Mutagens
- Teratogens
- Embryotoxicants
- Male-mediated teratogens